in its protective activity against cutaneous herpes simplex virus type 1 infection in hairless mice , bromovinyldeoxyuridine was clearly superior to other established antiherpes compounds such as 5-iodo-2'-deoxyuridine , 5-ethyl-2'-deoxyuridine , arabinosyl thymine , and arabinosyl ( e ) -5- ( 2-bromovinyl ) uracil when formulated at 10 % in dmso or azone-dmso .
C0040087
thymine
C0041917
uracil